Overjet Charting Assist
Overjet, Inc • Radiology • 02/23/2024
Device Purpose
Overjet Charting Assist is an AI-powered software designed to aid dental professionals by analyzing 2D dental radiographs (bitewing, periapical, and panoramic) to detect and segment tooth anatomy, assign tooth numbers, and identify existing restorative treatments. Its methodology relies on machine learning algorithms processing image data to provide semi-automated charting suggestions, with clinical studies demonstrating robust performance in identifying dental structures and a significant reduction in manual charting time, thereby supporting clinical workflow efficiency.
Summary
Overjet Charting Assist is a medical image management and processing system designed to aid dental professionals in the creation of dental charts. The system utilizes artificial intelligence-based image analysis to interpret 2D dental radiographs, including bitewing (BW), periapical (PA), and panoramic (Pano) images. Its core function is to detect and segment natural dental structures, such as tooth anatomy (enamel, pulp) and tooth numbering, as well as identify dental structures resulting from past restorative treatments, including implants, crowns, endodontic treatments, and fillings. The device is intended for use with BW and PA images for patients aged 5 and older with primary and/or permanent teeth, and with Pano radiographs for patients with only permanent teeth, operating as a cloud-based platform.\n\nStandalone performance testing on 634 diverse radiographic images demonstrated the device's capabilities. For past restorative structures, the system achieved an overall tooth-level sensitivity of 88.3% and high specificities for individual restoration types (e.g., 0.986 for fillings, 0.994 for crowns). Dental tooth anatomy (enamel/pulp) was detected with an overall sensitivity of 95.9%, with specific sensitivities of 94.9% for enamel and 85.6% for pulp. Tooth numbering classification accuracy reached 98.8%. The system significantly reduced manual charting operations by an average of 80.5%, enhancing efficiency. Performance was consistently validated across various demographics, U.S. geographical regions, and multiple X-ray sensor manufacturers, meeting predefined acceptance criteria; however, the device is intended as an assistive tool and does not replace a clinician's comprehensive review.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the AI algorithm differentiate between various types of restorative materials (e.g., amalgam vs. composite fillings) and how does this affect detection accuracy?; What is the impact of image quality variations (e.g., under/overexposure, artifacts, sensor types beyond those listed) on the performance of Overjet Charting Assist, particularly for subtle features?; The NPV for dental tooth anatomy is 0.710; what are the primary reasons for false negatives in anatomical detection (enamel, pulp), and what steps are being taken to improve this?; How does the 'semi-automatic' nature of the output, allowing user edits, impact overall workflow efficiency and inter-operator variability in final chart accuracy compared to fully manual or fully automatic systems?; For pediatric patients (age 5+), how does the system account for the dynamic nature of mixed dentition (e.g., exfoliating primary teeth, erupting permanent teeth) in tooth numbering and anatomical assessment accuracy?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class C (software safety classification); Qualifies as a cyber device under §524B (post-Dec 2023, networked)
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, HBOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly